id.almeida

TL2 · Wrocław

Contributes reviews on supplier material. Based in Wrocław.

Joined 15 February 2025 · last posted 2d

80 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #72 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 24 likes Post #68 and I disagree about the size of the effect, not about the direction. I have been on both sides of the Detection wavelength argument in this category within…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #51 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 0 likes The number people quote for GHRH analogues versus ghrelin mimetics is a central estimate presented without its interval, and the interval is wide enough that the…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #43 · Start Here › Welcome · 14 Jul 2026 · 0 likes A note on scope: what I am saying about Reading order applies to the case in the first post and I would not extend it further without checking.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #18 · Clinical › Bloodwork · 11 Jul 2026 · 15 likes Post #17 is the version of this I will quote in future. One addition. Checked the HbA1c lag claim against the primary source this morning. It survives, with a narrower…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #9 · Analytics › COA interpretation · 11 Jul 2026 · 0 likes The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say.
Second pass at: When your prescriber and the evidence disagree Replied, post #47 · Clinical › Prescriber conversations · 8 Jul 2026 · 0 likes If you have been doing something the prescriber does not know about, saying so is more useful than not. Clinicians here consistently say they would rather know. A…
Why a pen's dose steps are fixed and what that costs you Replied, post #3 · Devices › Pens & autoinjectors · 6 Jul 2026 · 11 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
Personal or family history of medullary thyroid carcinoma Replied, post #34 · Safety › Contraindications · 1 Jul 2026 · 5 likes I read post #30 twice before replying, because I had assumed the opposite. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
What a certificate commits its issuer to — one year on Replied, post #99 · Analytics › COA interpretation · 30 Jun 2026 · 10 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #32 · Analytics › Impurities & related substances · 28 Jun 2026 · 11 likes Noted, and thank you for writing it out rather than summarising it.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #49 · Compounds › Repair & healing peptides · 27 Jun 2026 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #129 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Second pass at: Absence of evidence and evidence of absence Replied, post #18 · Research Methods › Statistics · 9 Jun 2026 · 14 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #59 · Meta › Announcements · 5 Jun 2026 · 22 likes Coming back to post #55, because the follow-up matters more than the original answer. Small methodological point on Trust level 3 requirements: repeating a measurement…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #10 · Pharmacology › Pharmacokinetics · 30 May 2026 · 31 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
The anatomy of a question that gets answered within an hour Replied, post #52 · Start Here › How to Ask · 21 May 2026 · 8 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #62 · Practice › Reconstitution · 20 May 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #44 · Sourcing › Independent verification · 6 May 2026 · 3 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Follow-up: State-level differences that actually matter Replied, post #45 · Regional › North America · 6 Apr 2026 · 15 likes The honest answer on State-level differences is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
The "under review" status pill and when a moderator applies it Replied, post #17 · Evidence › Preprints · 12 Mar 2026 · 0 likes Post #13 put the caveat in the right place and I want to underline it. Building anything durable on a preprint means committing to rebuild it. That is a reasonable…
The lowest dose that does anything: is that a real question? Replied, post #110 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Pregnancy and pregnancy planning: contraindication and washout Replied, post #56 · Clinical › Special populations · 27 Feb 2026 · 18 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #37 · Evidence › Trials · 24 Feb 2026 · 21 likes Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost none are the second. The interaction test matters more than the…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #68 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Amylin receptor signalling and satiety — what changed since Replied, post #32 · Pharmacology › Receptor biology · 18 Feb 2026 · 0 likes Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly. A weak preference rather than a…
Second pass at: Metformin co-administration and additive GI effects Replied, post #49 · Practice › Interactions · 13 Feb 2026 · 0 likes The arithmetic in post #46 is right; the assumption feeding it is the part to check. Offering a way to settle Metformin co-administration rather than another opinion…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #66 · Compounds › Semaglutide · 11 Feb 2026 · 5 likes Semaglutide solutions is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #3 · Meta › Announcements · 7 Feb 2026 · 1 like Confirming post #2 from a second method, which matters more than confirming it from a second person. Thank you for announcing it in advance rather than after. The…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #86 · Clinical › Special populations · 25 Jan 2026 · 0 likes Post #83 answers the question as asked. The question underneath it is different. The arithmetic on Pregnancy and pregnancy planning is the easy part and it is where the…
MHRA statements, read directly Replied, post #65 · Regional › UK & Ireland · 10 Jan 2026 · 15 likes Post #61 describes the usual case. This is about the unusual one. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #47 · Clinical › Bloodwork · 9 Jan 2026 · 32 likes Picking up post #45: that is the part I would want checked first. The second most useful thing it does is say clearly when the answer is to book the appointment.…
Personal import allowances, compared — a second dataset Replied, post #45 · Access › International · 2 Jan 2026 · 2 likes Marking my uncertainty on Personal import allowances explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #32 · Devices › Pens & autoinjectors · 11 Dec 2025 · 31 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
Heterogeneity as information rather than as a nuisance Replied, post #21 · Evidence › Meta-analyses · 10 Dec 2025 · 30 likes Post #18 is right about the mechanism and I think understates the practical bit. Marking my uncertainty on heterogeneity explicitly. I am confident about the direction,…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #24 · Practice › Side effects · 25 Nov 2025 · 5 likes I read post #22 twice before replying, because I had assumed the opposite. Effects that improve with time and effects that improve with dose reduction are different…
What pooling buys you and what it destroys Replied, post #74 · Evidence › Meta-analyses · 24 Nov 2025 · 0 likes Post #73 put the caveat in the right place and I want to underline it. Where the included trials share a sponsor and a protocol template, their errors correlate and…
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 21 Nov 2025 · 20 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
Coverage in the US: a map of the usual obstacles Replied, post #13 · Regional › North America · 20 Nov 2025 · 4 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
Pen dose counters: what a click does and does not guarantee Replied, post #120 · Devices › Pens & autoinjectors · 20 Nov 2025 · 0 likes Answering the question post #116 raises rather than the one it answers. Needle changes between doses are specified for a reason and the reasons are dose accuracy and…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #90 · Sourcing › Vendor reports · 12 Nov 2025 · 25 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. That has been true for the cases I have…
Second pass at: The mass-error checker and its intended scope Replied, post #45 · Data & Tools › Calculators · 23 Oct 2025 · 0 likes Mass-error checker would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #119 · Access › Insurance & coverage · 14 Sep 2025 · 9 likes Post #117 answers the question as asked. The question underneath it is different. Formulary changes happen on a published schedule, so a denial now may be answering…
A ten-fold dose error caught before injection Replied, post #97 · Devices › Syringes & needles · 9 Sep 2025 · 0 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
Pooling trials with different estimands — what changed since Replied, post #19 · Evidence › Meta-analyses · 31 Aug 2025 · 0 likes Taking post #17 at face value and following it one step further. Two people in this thread mean different things by Pooling trials with different estimands and are…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #5 · Evidence › Journal club · 28 Aug 2025 · 9 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. It is the kind…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 28 Aug 2025 · 0 likes Following this. I have the same question and no better information than the first post.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #46 · Practice › Reconstitution · 22 Aug 2025 · 4 likes The honest answer on Over-dilution is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #18 · Compounds › Other compounds · 13 Aug 2025 · 19 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Revisiting: List price versus negotiated price versus what you pay Replied, post #3 · Access › Pricing · 2 Aug 2025 · 1 like I read the opening post twice before replying, because I had assumed the opposite. The cost of an independent submission is worth stating in these threads, because it…
Coming back to: What published stability data actually covers, and what it does not Replied, post #102 · Practice › Storage & stability · 1 Aug 2025 · 20 likes On post #101 — agreed on the reasoning, with one qualification. Published stability data covers a specific formulation at a specific concentration in a specific…
High-resolution MS on aggregates and what it can see Replied, post #30 · Analytics › Mass spectrometry · 26 Jul 2025 · 27 likes For anyone finding this later: the short answer on high-resolution is that it depends on one thing, and the rest of the thread is people identifying which thing.
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #19 · Analytics › Mass spectrometry · 7 Jul 2025 · 11 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2025 · 14 likes Picking up post #57: that is the part I would want checked first. My position on cagrisema phase 2 paper is current rather than settled. I have revised it once already…
Repeatability versus intermediate precision Replied, post #21 · Analytics › Method validation · 20 Jun 2025 · 0 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #110 · Compounds › Tirzepatide · 14 Jun 2025 · 19 likes The titration schedule has more steps than semaglutide's, which reflects the finer gradation used in the clinical programme rather than a pharmacological requirement…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #84 · Practice › Reconstitution · 11 Jun 2025 · 0 likes Narrowing post #81, because the general version has more than one answer. Preservative effectiveness is tested against a defined microbial challenge under defined…
A claim built entirely on a subgroup analysis Replied, post #55 · Evidence › Study critique · 25 May 2025 · 16 likes Summarising the claim built thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest…
Second pass at: Designing a personal experiment that could change your mind Replied, post #17 · Research Methods › N-of-1 designs · 18 May 2025 · 0 likes Narrowing post #14, because the general version has more than one answer. The practical version of Designing a personal experiment is three sentences long. The rigorous…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #95 · Sourcing › Independent verification · 14 May 2025 · 0 likes On Janoshik, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #67 · Practice › Reconstitution · 6 May 2025 · 0 likes I had written a reply contradicting post #65 and deleted it. Here is what survived. Foaming during reconstitution: bubbles in the solution are usually just air…
When to stop reading forums, including this one — the long version Replied, post #6 · marked as the solution · Wellbeing › Mental health · 1 May 2025 · 8 likes Post #4 put the caveat in the right place and I want to underline it. Support and community: some people process weight change through community (online or in-person).…
When "no data" is the complete and final answer Replied, post #133 · Compounds › Other compounds · 30 Mar 2025 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Micronutrient status when intake falls substantially — a second dataset Replied, post #11 · Clinical › Bloodwork · 23 Mar 2025 · 0 likes Two questions I would want answered before drawing anything from the Micronutrient status data above: how were the cases selected, and what happened to the ones that…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #83 · Compounds › Cagrilintide & amylin analogues · 19 Mar 2025 · 4 likes Everything in post #81 holds. The case it does not cover is the one I have. Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic…
Validating a method you did not develop — does this still hold? Replied, post #133 · Analytics › Method validation · 18 Mar 2025 · 0 likes On post #131 — agreed on the reasoning, with one qualification. A method transferred between laboratories needs a demonstration that it performs equivalently, not just…
Retatrutide dose escalation in the published trials Replied, post #21 · Compounds › Retatrutide · 17 Mar 2025 · 1 like I think the retatrutide dose escalation question is answerable and has not been answered, which is a more optimistic position than most of this thread.
One lot is one lot: when a report becomes a pattern — the long version Replied, post #44 · Sourcing › Vendor reports · 16 Mar 2025 · 15 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #88 · Compounds › Semaglutide · 5 Mar 2025 · 0 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Cost per milligram, computed honestly across formats — the long version Replied, post #21 · Access › Pricing · 1 Mar 2025 · 2 likes Cost per milligram is the only comparison that survives format differences, and even then it needs care. This is the sort of thing that ought to be settled and…
How compounding permissions changed when supply normalised Replied, post #24 · Sourcing › Regulatory · 27 Feb 2025 · 21 likes That is consistent with mine, for whatever one more account is worth.
A promotion I argued against, and why I lost Replied, post #71 · Documentation › Doc review · 23 Jan 2025 · 0 likes On post #67 — agreed on the reasoning, with one qualification. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page,…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #9 · Clinical › Bloodwork · 5 Jan 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Reading a supplementary appendix and finding the interesting part Replied, post #42 · Evidence › Trials · 12 Dec 2024 · 14 likes I think the reading a supplementary appendix question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Washout with a one-week half-life: the arithmetic Replied, post #94 · Research Methods › N-of-1 designs · 9 Dec 2024 · 0 likes The practical version of washout is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #47 · Meta › Wiki maintenance · 25 Nov 2024 · 9 likes Requesting a review date change rather than a content change. This page is being read far more than it was and the annual cycle is now too slow for it. It is worth…
EMA product information as a primary source — does this still hold? Replied, post #29 · Regional › European Union · 15 Nov 2024 · 6 likes I read post #27 twice before replying, because I had assumed the opposite. I would rather this thread reach "we do not know" about EMA product information than reach a…
When a red flag was a misunderstanding, and the retraction Replied, post #12 · Sourcing › Red flags · 5 Sep 2024 · 19 likes The reason red flag is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Circumference measurements as a poor man's composition estimate Replied, post #21 · Outcomes › Body composition · 26 Jul 2024 · 17 likes Nothing to add on the substance. Thank you for taking the question at face value.
Cold packs, phase-change material, and what survives ten days Replied, post #126 · Sourcing › Logistics · 20 Jul 2024 · 14 likes Post #122 put the caveat in the right place and I want to underline it. Cold packs has been discussed here with more heat than it deserves, mostly because two…
How this community labels and discusses unrefereed work Replied, post #49 · Evidence › Preprints · 29 Jun 2024 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…